Dynamic analysis of peritoneal dialysis associated peritonitis

被引:4
|
作者
Hotchkiss, JR
Hermsen, ED
Hovde, LB
Simonson, DA
Rotschafer, JC
Crooke, PS
机构
[1] Univ Pittsburgh, CRISM Lab, Pittsburgh, PA 15260 USA
[2] Vanderbilt Univ, Biomath Study Grp, Nashville, TN USA
[3] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[4] Vanderbilt Univ, Dept Math, Nashville, TN USA
关键词
D O I
10.1097/01.MAT.0000145238.98158.F0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Peritoneal dialysis associated peritonitis (PDAP) has a historical incidence of approximately 0.3 to 0.5 episodes per patient per year; it represents the leading cause for hospitalization in patients on peritoneal dialysis (PD) and imposes a significant burden of morbidity. PDAP is unique in that each dialysis exchange removes a relatively large fraction of the bacteria laden free intraperitoneal fluid. The attendant removal of bacteria existing in the fluid phase (planktonic bacteria) may interact with bacterial growth to modulate the rate at which the peritoneal burden of microorganisms is reduced. We investigated the potential interactions between bacterial growth dynamics, multiphase bacterial kinetics, and mechanical clearance of microorganisms using simple mathematical analyses based upon in vitro data regarding bacterial growth kinetics in peritoneal dialysate. There are strong dynamic interactions predicted between fluid phase bacterial kinetics, dialysis prescription, and the mechanical clearance of planktonic peritoneal bacteria. There are also strong interactions between fluid phase bacterial kinetics and the kinetics of biofilm/sanctuary site formation and clearance. More frequent exchanges might significantly hasten the clearance of intraperitoneal planktonic bacteria in the absence of catheter-associated bacterial biofilm. The formation of bacteria laden biofilm raises the possibility of a "commensal state," in which ongoing mechanical clearance limits the total peritoneal bacterial burden.
引用
收藏
页码:568 / 576
页数:9
相关论文
共 50 条
  • [1] Peritoneal Fluid Analysis in Peritoneal Dialysis-Associated Peritonitis
    Perl, Jeffrey
    Harel, Ziv
    Nessim, Sharon J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (21): : 2157 - 2158
  • [2] Peritoneal Dialysis-Associated Peritonitis
    Szeto, Cheuk-Chun
    Li, Philip Kam-Tao
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 1100 - 1105
  • [3] Empyema associated with peritoneal dialysis peritonitis
    Wen, Yao-Ko
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2024,
  • [4] Tuberculous Peritonitis Associated with Peritoneal Dialysis
    Waness, Abdelkarim
    Al Shohaib, Saad
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (01) : 44 - 47
  • [5] Treatment for peritoneal dialysis-associated peritonitis
    Ballinger, Angela E.
    Palmer, Suetonia C.
    Wiggins, Kathryn J.
    Craig, Jonathan C.
    Johnson, David W.
    Cross, Nicholas B.
    Strippoli, Giovanni F. M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (04):
  • [6] Vancomycin in peritoneal dialysis-associated peritonitis
    Bailie, GR
    Eisele, G
    [J]. SEMINARS IN DIALYSIS, 1996, 9 (05) : 417 - 423
  • [7] Peritonitis by Clostridium innocuum associated to peritoneal dialysis
    Aroca-Ferri, Maria
    Suarez-Hormiga, Laura
    Bosch-Benitez-Parodi, Elvira
    Bolanos-Rivero, Margarita
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (02) : 192 - 193
  • [8] Peritoneal-dialysis-associated Penicillium peritonitis
    Chang, HR
    Shu, KH
    Cheng, CH
    Wu, MJ
    Chen, CH
    Lian, JD
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (03) : 250 - 252
  • [9] Treatment for peritoneal dialysis-associated peritonitis
    Wiggins, K. J.
    Craig, J. C.
    Johnson, D. W.
    Strippoli, G. F.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [10] Peritonitis in peritoneal dialysis
    Voinescu, CG
    Khanna, R
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (04): : 249 - 260